UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000056170 |
|---|---|
| Receipt number | R000064181 |
| Scientific Title | Sources, acquisition routes and timing, and methods and evaluation of information on health topics explored by pregnant women and their partners in the perinatal and postpartum periods: a scoping review protocol |
| Date of disclosure of the study information | 2024/11/16 |
| Last modified on | 2025/05/19 09:59:33 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Sources, acquisition routes and timing, and methods and evaluation of information on health topics explored by pregnant women and their partners in the perinatal and postpartum periods: a scoping review protocol
Acronym
Sources, acquisition routes and timing, and methods and evaluation of information on health topics explored by pregnant women and their partners in the perinatal and postpartum periods: a scoping review protocol
Scientific Title
Sources, acquisition routes and timing, and methods and evaluation of information on health topics explored by pregnant women and their partners in the perinatal and postpartum periods: a scoping review protocol
Scientific Title:Acronym
Sources, acquisition routes and timing, and methods and evaluation of information on health topics explored by pregnant women and their partners in the perinatal and postpartum periods: a scoping review protocol
Region
| Japan |
Condition
Condition
Pregnancy, labor, delivery, and postpartum period
Classification by specialty
| Obstetrics and Gynecology | Nursing | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To identify what are the sources of health information obtained by pregnant women, their partners, mothers, and fathers and what are the topics they obtain information on in the perinatal and postpartum periods.
Basic objectives2
Others
Basic objectives -Others
To identify how and when pregnant women, their partners, mothers, and fathers obtain health information in the perinatal and postpartum periods, and what methods the study use to assess the quality of the information obtained by pregnant women, their partners, mothers, and fathers, and what the results of the assessments are.
Trial characteristics_1
Exploratory
Trial characteristics_2
Others
Developmental phase
Not applicable
Assessment
Primary outcomes
The sources of health information and the topics identified by pregnant women, their partners, mothers, and fathers in the perinatal and postpartum periods.
Key secondary outcomes
For pregnant women, their partners, mothers, and fathers, what are their sources of health information, what are the topics they obtain information on in the perinatal and postpartum periods,
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
The Population, Concept, and Context (PCC) framework by the Joanna Briggs Institute (JBI) methodology will be used for establishing the eligibility criteria. The inclusion criteria will be as follows:
P: pregnant women, and their partners, mothers, and fathers in the perinatal and postpartum periods.
C: sources of health information and topics that the population obtained as regards pregnancy, labor, delivery, and postpartum period; routes and timing of information acquisition, and methods and results of the evaluation of the quality of information. Although the routes and timing of information acquisition as well as the evaluation of information quality have not yet been investigated in previous studies, these items will be included in this scoping review.
C: Open (i.e., not limited by country or culture).
This scoping review will consider descriptive cross-sectional studies. Qualitative studies and reviews that meet the inclusion criteria will also be considered. If reviews are included, the articles cited in these reviews will be excluded.
Key exclusion criteria
Studies and reviews that are written in languages other than English or Japanese and are published before 2017, and conference abstracts and protocols.
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Yuriko |
| Middle name | |
| Last name | Tadokoro |
Organization
Tokyo Healthcare University
Division name
Chiba Faculty of Nursing
Zip code
273-8710
Address
1-1042-2 Kaijincho nishi, Funabashi-shi, Chiba 273-8710, Japan
TEL
047-495-7751
y-tadokoro@thcu.ac.jp
Public contact
Name of contact person
| 1st name | Yuriko |
| Middle name | |
| Last name | Tadokoro |
Organization
Tokyo Healthcare University
Division name
Chiba Faculty of Nursing
Zip code
273-8710
Address
1-1042-2 Kaijincho nishi, Funabashi-shi, Chiba 273-8710, Japan
TEL
047-495-7751
Homepage URL
y-tadokoro@thcu.ac.jp
Sponsor or person
Institute
Tokyo Healthcare University
Institute
Department
Personal name
Funding Source
Organization
JSPS KAKENHI Grant Number 24K20356.
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
N/A
Address
N/A
Tel
N/A
N/A
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 11 | Month | 16 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2024 | Year | 07 | Month | 31 | Day |
Date of IRB
| 2024 | Year | 07 | Month | 31 | Day |
Anticipated trial start date
| 2024 | Year | 08 | Month | 01 | Day |
Last follow-up date
| 2026 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
This is a scoping review, therefore, no patient registration is planned. Terefore, no patients will be enrolled. Additionally, ethical approval for the study is not required. Since all fields must be completed to register the study on UMIN, appropriate entries have been made in each section.
Management information
Registered date
| 2024 | Year | 11 | Month | 16 | Day |
Last modified on
| 2025 | Year | 05 | Month | 19 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064181
